These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 18953889)

  • 1. [Glaucoma neuroprotection--how far is it from a dream to reality].
    Ge J
    Zhonghua Yan Ke Za Zhi; 2008 May; 44(5):385-7. PubMed ID: 18953889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent clinical findings with memantine should not mean that the idea of neuroprotection in glaucoma is abandoned.
    Osborne NN
    Acta Ophthalmol; 2009 Jun; 87(4):450-4. PubMed ID: 19141144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. History of neuroprotection and rationale as a therapy for glaucoma.
    Levin LA; Peeples P
    Am J Manag Care; 2008 Feb; 14(1 Suppl):S11-4. PubMed ID: 18284310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotection: extrapolating from neurologic diseases to the eye.
    Danesh-Meyer HV; Levin LA
    Am J Ophthalmol; 2009 Aug; 148(2):186-191.e2. PubMed ID: 19464671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuroprotection in glaucoma].
    Kuprjanowicz L; Karczewicz D
    Ann Acad Med Stetin; 2007; 53 Suppl 1():22-9. PubMed ID: 19425476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optic nerve and neuroprotection strategies.
    Osborne NN; Chidlow G; Layton CJ; Wood JP; Casson RJ; Melena J
    Eye (Lond); 2004 Nov; 18(11):1075-84. PubMed ID: 15534592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice.
    Zhong L; Bradley J; Schubert W; Ahmed E; Adamis AP; Shima DT; Robinson GS; Ng YS
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1212-8. PubMed ID: 17325165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin: a candidate neuroprotective agent in the treatment of glaucoma.
    Tsai JC; Song BJ; Wu L; Forbes M
    J Glaucoma; 2007 Sep; 16(6):567-71. PubMed ID: 17873720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination for glaucoma: dream or reality?
    Schwartz M
    Brain Res Bull; 2004 Feb; 62(6):481-4. PubMed ID: 15036561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and cell-based approaches for neuroprotection in glaucoma.
    Lebrun-Julien F; Di Polo A
    Optom Vis Sci; 2008 Jun; 85(6):417-24. PubMed ID: 18521011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma.
    Hains BC; Waxman SG
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4164-9. PubMed ID: 16249495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translational Pharmacology in Glaucoma Neuroprotection.
    Levin LA
    Handb Exp Pharmacol; 2017; 242():209-230. PubMed ID: 27752844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prospects in the medical treatment of glaucomatous neuropathy. Basics of neuroprotection].
    Detry-Morel M
    J Fr Ophtalmol; 1999 Feb; 22(1):122-34. PubMed ID: 10221206
    [No Abstract]   [Full Text] [Related]  

  • 14. [Contemporary possibilities and perspectives in the treatment of glaucoma].
    Czepita D
    Ann Acad Med Stetin; 2005; 51(1):27-31. PubMed ID: 16496599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Glaucoma as primary optic neuropathy].
    Nicolae A; Stefan C
    Oftalmologia; 2001; 54(4):5-8. PubMed ID: 12035602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease progression and the need for neuroprotection in glaucoma management.
    Varma R; Peeples P; Walt JG; Bramley TJ
    Am J Manag Care; 2008 Feb; 14(1 Suppl):S15-9. PubMed ID: 18284311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complementary therapy for the treatment of glaucoma: a perspective.
    Ritch R
    Ophthalmol Clin North Am; 2005 Dec; 18(4):597-609. PubMed ID: 16314222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuroprotection in glaucoma].
    Stefan C; Melinte-Dumitrica D; Selaru D; Musat O; Zemba M; Serghiescu I
    Oftalmologia; 2010; 54(2):7-10. PubMed ID: 20827905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trials in neuroprotection.
    Whitcup SM
    Prog Brain Res; 2008; 173():323-35. PubMed ID: 18929119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotection in glaucoma: drug-based approaches.
    Cheung W; Guo L; Cordeiro MF
    Optom Vis Sci; 2008 Jun; 85(6):406-16. PubMed ID: 18521010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.